Showing results (211-220 of 517) with videos related to
Sort By:
Pageof 52
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1997
Induction of the acute-phase reaction increases heparin-binding proteins in plasmaE Young, T J Podor, T Venner, et al.Thrombosis Research|December 15, 1985
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbitsG Agnelli, M R Buchanan, F Fernandez, et al.Blood|August 15, 1995
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvariaS G Shaughnessy, E Young, P Deschamps, et al.The New England Journal of Medicine|June 25, 1981
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosisR Hull, J Hirsh, D L Sackett, et al.Thrombosis and Haemostasis|July 1, 1995
Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolismJ Hirsh, S Siragusa, B Cosmi, et al.Water Resources Research|January 6, 2015
Nebraska's groundwater legacy: Nitrate contamination beneath irrigated croplandMary E Exner, Aaron J Hirsh, Roy F SpaldingArchives of Internal Medicine|December 27, 1993
Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasoundA Cogo, A W Lensing, P Prandoni, et al.Thrombosis and Haemostasis|June 1, 1992
Heparin binding to plasma proteins, an important mechanism for heparin resistanceE Young, M Prins, M N Levine, et al.Blood|October 1, 1980
Immunodepletion of human plasma factor VIIIF Ofosu, K Cassidy, M A Blajchman, et al.European Heart Journal|July 1, 1995
Advances in antithrombotic drug therapy for coronary artery diseaseC S Rihal, M Flather, J Hirsh, et al.Pageof 52